Home › Respiratory Distress Syndrome › Washington › Seattle
Respiratory Distress Syndrome clinical trials in Seattle, WA
6 studies for Respiratory Distress Syndrome are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
RecruitingPhase 2
- Swedish Medical Center, Seattle
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
RecruitingPhase 2
- Swedish Medical Center, Seattle
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
RecruitingPhase 2
- Swedish Medical Center, Seattle
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
RecruitingPhase 2
- Swedish Medical Center, Seattle
Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients
RecruitingPhase 2
- Harborview Medical Center, Seattle
- University of Washington, Seattle
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
RecruitingPhase 3
- University of Washingont/Harborview Medical Center, Seattle
Respiratory Distress Syndrome trials in other cities
- Houston, TX11 studies
- New York City, NY10 studies
- Denver, CO9 studies
- Durham, NC8 studies
- Boston, MA8 studies
- West Jordan, UT8 studies
- Oklahoma City, OK7 studies
- Cleveland, OH7 studies
- Birmingham, AL7 studies
- Rochester, MN7 studies
- Washington, DC7 studies
- Detroit, MI7 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)50 studies
- Prostate Cancer44 studies
- Breast Cancer40 studies
- Acute Myeloid Leukemia40 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer31 studies
- Multiple Myeloma22 studies
- Pancreatic Cancer22 studies
- Myelodysplastic Syndromes21 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.